Advancing the Frontier of Oligonucleotide Therapeutics
The OTS Regional Meeting Australia - 2026 stands as a pivotal gathering for the global scientific community.
This conference serves as a dedicated platform for researchers, clinicians, and industry leaders to converge on the latest breakthroughs in oligonucleotide therapeutics.
By fostering deep collaboration and sharing visionary insights, we aim to accelerate the development of precision medicine solutions that redefine clinical outcomes and scientific innovation.
Why Attend OTS Australia
2026?
Join leading researchers, clinicians, biotechnology professionals and industry experts working across oligonucleotide and RNA therapeutics. OTS Australia 2026 will provide an opportunity to discover emerging research, exchange scientific insights, build collaborations and explore the future of RNA-based medicines.
- Hear from leading Australian and international experts.
- Discover advances in oligonucleotide and RNA therapeutics.
- Participate in scientific sessions and panel discussions.
- Connect with researchers, clinicians and industry leaders.
- Explore collaboration, research and commercialisation opportunities.
- Present your research through oral or poster presentations.